Cancer Cell International is an open access, peer-reviewed, online journal that considers research on cancer cells, originating largely from work using cell culture techniques. It serves the world as a publication of the International Federation for Cell Biology. Much of cancer work relates to biolo...
Consequently, cancer stem cells (CSCs) can self-renew and differentiate into various cell types. Understanding the mechanisms that sustain their persistence is crucial for developing effective therapies. Exosomes have recently gained interest as vehicles for intercellular communication between CSCs and non-...
Cites per document 2022 22.989 Cites per document 2023 21.363 % International Collaboration 200220052008201120142017202020230204060 International Collaboration accounts for the articles that have been produced by researchers from several countries. The chart shows the ratio of a journal's documents signed by ...
Review Open access Published: 19 May 2022 Volume 22, article number 196, (2022) Cite this article Download PDF You have full access to this open access article Cancer Cell International Aims and scope Submit manuscript Masoumeh Sharifi-Azad, Marziyeh Fathi, William C. Cho, Abolfazl ...
Programmed death-1 (PD-1)/programmed death-ligand 1 (PD-L1) blockade therapy has become a game-changing therapeutic approach revolutionizing the treatment setting of human malignancies, such as renal cell carcinoma (RCC). Despite the remarkable clinical
analyzed, our methodology produced predictive models for four additional tumor types: breast cancer (BRCA), cervical squamous cell carcinoma (CESC), sarcoma (SARC), and uterine corpus endometrial carcinoma (UCEC), as well as quite a few predictive models for additional cancers and outcomes that ...
Glioma is the most common and lethal type of brain tumor, and it is characterized by unfavorable prognosis and high recurrence rates. The reprogramming of energy metabolism and an immunosuppressive tumor microenvironment (TME) are two hallmarks of tumors
After several decades, therapeutic cancer vaccines now show signs of efficacy and potential to help patients resistant to other standard-of-care immunotherapies, but they have yet to realize their full potential and expand the oncologic armamentarium. He
Integrative insights and clinical applications of single-cell sequencing in cancer immunotherapy High-throughput single-сell sequencing in cancer research 03 May 2022 Background The immune system monitors the human body and eradicates abnormal cells. This intricate surveillance system operates through a co...
Programmed death-1 (PD-1)/programmed death-ligand 1 (PD-L1) blockade therapy has become a game-changing therapeutic approach revolutionizing the treatment setting of human malignancies, such as renal cell carcinoma (RCC). Despite the remarkable clinical